Indicators
LISA (n=75)
InSURE (n=75)
P-value
Gestational Age (weeks), Mean ± SD 31.41±0.30 31.36 ± 0.69 0.57*
Gestational age group
28 to < 32 weeks, n (%) 49 50 0.90**
32 to < 34 weeks, n (%) 23 23
≥ 34 weeks, n (%) 03 02
SGA n (%) 32 35 0.74***
AGA n (%) 43 40
LGA n (%) 00 00
Birth weight, g, Mean ± SD 1226 (±176) 1261.5 (±244) 0.30*
Birth weight group
ELBW (<1000 g) 08 09 0.49**
VLBW (1000–1499 g) 59 62
LBW (1500–2499 g) 08 04
Gender
Male, n (%) 39 41 0.87***
Female, n (%) 36 34
APGAR Score, Median (IQR)
1 min 5(4-6) 5(5-6) 0.25#
5 min 7(7-8) 8(7-8) 0.56#
Mode of delivery
Vaginal, n (%) 55(73.33%) 52(69.33%) 0.71***
Caesarean, n (%) 20(26.66%) 23(30.66%)
Antenatal steroids
Complete course, n (%) 22 (29.33%) 21 (28 %) 0.98**
Incomplete course, n (%) 37 (49.33%) 38(50.66%)
Not received, n (%) 16(21.33%) 16(21.33%)
Antenatal complications
GDM, n (%) 03 02 0.97**
PIH 29 32
ECLAMPSIA 05 04
APH 16 15
PPROM 24 22
MAX PEEP before surfactant, Median (IQR) 7 (6-7) 7 (6-7) 0.87#
Age at surfactant therapy (hrs), Mean ± SD
2.98 ± 0.70
2.8 ± 0.79
0.13*
SAS Score before surfactant, Median (IQR) 5(5-6) 5 (5-6) 0.89#